These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 33401106)

  • 1. COVID-19 and chronic fatigue syndrome: Is the worst yet to come?
    Wostyn P
    Med Hypotheses; 2021 Jan; 146():110469. PubMed ID: 33401106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putative glymphatic signature of chronic fatigue syndrome: A new view on the disease pathogenesis and therapy.
    Wostyn P; De Deyn PP
    Med Hypotheses; 2018 Sep; 118():142-145. PubMed ID: 30037603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic intracranial hypertension: The veno glymphatic connections.
    Lenck S; Radovanovic I; Nicholson P; Hodaie M; Krings T; Mendes-Pereira V
    Neurology; 2018 Sep; 91(11):515-522. PubMed ID: 30201744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.
    Komaroff AL; Lipkin WI
    Trends Mol Med; 2021 Sep; 27(9):895-906. PubMed ID: 34175230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the glymphatic system in idiopathic intracranial hypertension.
    Steinruecke M; Tiefenbach J; Park JJ; Kaliaperumal C
    Clin Neurol Neurosurg; 2022 Nov; 222():107446. PubMed ID: 36183631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Arachnoid Granulations and the Glymphatic System in the Pathophysiology of Idiopathic Intracranial Hypertension.
    Mondejar V; Patsalides A
    Curr Neurol Neurosci Rep; 2020 May; 20(7):20. PubMed ID: 32444998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
    J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID.
    Stefano GB
    Med Sci Monit; 2021 Feb; 27():e931447. PubMed ID: 33633106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic fatigue syndrome and idiopathic intracranial hypertension: Different manifestations of the same disorder of intracranial pressure?
    Higgins JNP; Pickard JD; Lever AML
    Med Hypotheses; 2017 Aug; 105():6-9. PubMed ID: 28735654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
    Carod-Artal FJ
    Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Underlying Role of the Glymphatic System and Meningeal Lymphatic Vessels in Cerebral Small Vessel Disease.
    Tian Y; Zhao M; Chen Y; Yang M; Wang Y
    Biomolecules; 2022 May; 12(6):. PubMed ID: 35740873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysautonomia and Implications for Anosmia in Long COVID-19 Disease.
    Vallée A
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudotumor Cerebri and Glymphatic Dysfunction.
    Bezerra MLS; Ferreira ACAF; de Oliveira-Souza R
    Front Neurol; 2017; 8():734. PubMed ID: 29387036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Intracranial Hypertension: Glymphedema of the Brain.
    Nicholson P; Kedra A; Shotar E; Bonnin S; Boch AL; Shor N; Clarençon F; Touitou V; Lenck S
    J Neuroophthalmol; 2021 Mar; 41(1):93-97. PubMed ID: 33034442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long COVID: Is it really myalgic encephalomyelitis? Bibliographic review and considerations].
    Espinosa Rodríguez P; Martínez Aguilar A; Ripoll Muñoz MP; Rodríguez Navarro MÁ
    Semergen; 2022; 48(1):63-69. PubMed ID: 34531126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.
    Paul BD; Lemle MD; Komaroff AL; Snyder SH
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34400495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Glymphatic System (En)during Inflammation.
    Mogensen FL; Delle C; Nedergaard M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome.
    Chaves-Filho AM; Braniff O; Angelova A; Deng Y; Tremblay MÈ
    Brain Res Bull; 2023 Sep; 201():110702. PubMed ID: 37423295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
    Simani L; Ramezani M; Darazam IA; Sagharichi M; Aalipour MA; Ghorbani F; Pakdaman H
    J Neurovirol; 2021 Feb; 27(1):154-159. PubMed ID: 33528827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.